Member Info for dyl79

I think there are some serious questions for the BOD, ie why they refused a 40 odd pence deal in March to now suggest accepting a 1p deal. If there wasnt jobs involved, I’d rather they go bust rather than make Branson richer!

the bod come out straight away and reject the offer if its around 10p.

what the offer is. Will the BOD accept, and if so why? Do they reject and go on their own? Does IAG come in with a counter offer?

Sky Sources: A consortium led by Virgin Atlantic will announce a takeover bid for the regional airline Flybe tomorrow. Sky News understands Virgin Atlantic will be the largest shareholder in a new airline group comprising Flybe and Stobart Air.

I’d just sit tight on this one. Outlook is looking very good. I just think the market needs more concrete data and evidence at the moment, which is understandable. To me there is very good potential to multibag. But it may not be a smooth ride.

So we await the YODA results in Q1. I assume they will release the Japanese results at the same time. Then what? New trail or can it be fastracked? If a new trial then how long will that take? 12 months. Lots of unknowns at the moment but still think this will eventually come good. I’m avaeraging at around 80p so its not too bad for me at the moment. Think there is potential for quite a few quid when it all falls together. Only question is when.

No I dont think the Japanese results took the steroids interaction into account. Thats what the CEO said in his last interview.

I’d be really happy with 50p. I’d take 30p - 50p. 20p - 30p reluctantly.

We now know there is a very good chance that traumakine will most probably work. It is just a matter of time until it is produced. This is a much better place than a few months back when it failed the phase 111 interest trial. The only thing that we are unsure of is whether we need to rerun a phase 111 trial. In the scheme of things its not a massive issue. It will just take longer. Do they need a partner - I dont know.

Quickly looking through the ards website there is potential for hundreds of thousands of patients worldwide, even in the millions. 160,000 thousand in the USA alone suffers from ards per year.

Another good rns following the last one. Always felt quietly confident with this share even if I hold well into 2019. Let’s see what happens next - partner onboard maybe after yoda results?

I think £1.50 on a good yoda result may be underestimating it a bit. I could see it going higher. What happens adter yoda will affect the sp the most. If it somehow can be fastracked or a partner brought onboard, it will probably go even higher. If stage 3 needs to be repeated it will then probably stay at around the £1.50/£2.50 mark, imo.

People saying that yoda due q4 - do you have a link for this please? (Interview on the 01/11/18 said q1 2019)

Assuming YODA is successful (very good chance it will be) - I take it that a partner will then come on board to push things forward, which I assume will be a rerun of the phase 3 trial again?

In this interview from the 1st November 2018, the CEO of Faron says that ‘High hopes are not needed here either’ in regards to the japanese results and that steriods were also in use during this trial (same ad interest trial). (See around 2 min into the interview). The japanese trial has been done and the results are due in the last quarter (so next three weeks). YODA is due in Q1 2019. https://www.proactiveinvestors.co.uk/companies/stocktube/11083/follow-up-study-points-to-even-bigger-opportunity-for-traumakine-faron-pharma-ceo-11083.html

short being opened though? Who would lend that many shares though and who would have the means to borrow that many shares?

Could be - how would you know if they were buys though? They are showing as sells.

New to this but dumping shares currently, in the hope that the jap results are published next week. We know they wont be good. They hope the share price falls and they then close at a lower price, and make some profit in the meantime??

cut and pasted from thestreet.com Could it be in anticipation of the japanese results?? “Not that individual investors are usually the ones to short-sell stocks. Many short-sellers are hedge funds, trying to protect themselves during a bearish market or worse. Short-selling is done at times, not just to possibly make a profit, but try to avoid any more disastrous losses. When the market is in a downturn, it can be difficult to find a stock you can profit from while buying. Short-selling a stock gives investors the option to make money in environments where it has become harder to do so. It is also done to mitigate losses from a declining stock in your portfolio. Say you own shares in a stock that has gone from a value of $150 to $125. You see the writing on the wall and don't anticipate it going back up anytime soon. You could sell it to try to avoid deeper losses. Or, an investor looking to get a little money back could short-sell their shares, and -- if the value continues to decline -- buy them back and perhaps be able to pocket some money from the whole ordeal”.

Would a large shareholder short a stock though? And use so many shares?